Caluire et Cuire, France

Marie-Françoise Klucker

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marie-Francoise Klucker: Innovator in Immuno-Adjuvant Emulsions

Introduction

Marie-Francoise Klucker is an accomplished inventor based in Caluire et Cuire, France. She has made significant contributions to the field of immunology, particularly through her work at Sanofi Pasteur, a global leader in vaccine development and production. With one notable patent to her name, Klucker exemplifies the innovative spirit of contemporary medicine.

Latest Patents

Marie-Francoise Klucker holds a patent for an "Immuno-adjuvant emulsion." This invention relates to an oil-in-water adjuvant emulsion designed to improve the efficacy of vaccines. The technology involves a process for preparing an immunogenic composition where at least one vaccine antigen is mixed with the oil-in-water emulsion, which is created utilizing a temperature-variation phase-inversion process. This innovative approach could enhance vaccine performance by increasing immune responses.

Career Highlights

Klucker has developed her career at Sanofi Pasteur, where she leverages her expertise in immunology and emulsions to advance vaccine research and development. Her work focuses on creating formulations that maximize the effectiveness of immunogenic agents, contributing to public health and disease prevention efforts worldwide.

Collaborations

Throughout her career, Klucker has collaborated with notable colleagues such as Francois Dalencon and Patricia Probeck-Quellec. These partnerships reflect a shared commitment to advancing vaccine technologies and highlight the importance of teamwork in scientific advancements.

Conclusion

Marie-Francoise Klucker represents a vital part of the innovation landscape in the pharmaceutical and vaccine industries. Her patented work on immuno-adjuvant emulsions stands as a testament to her dedication to improving vaccine efficacy. As she continues her work at Sanofi Pasteur, Klucker undoubtedly has more contributions to make in the pursuit of health solutions for the global community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…